Mimedx (MDXG) Cash from Discontinued Operations (2023 - 2024)
Mimedx's (MDXG) quarterly Cash from Discontinued Operations came in at 1000.0 in Q4 2024, down 99.9% year-on-year from 987000.0 in Q1 2024, and up 200.0% quarter-over-quarter from 1000.0 in Q3 2024.
Mimedx (MDXG) Cash from Discontinued Operations (2023 - 2024) Analysis & Trends
Mimedx has disclosed Cash from Discontinued Operations across 2 years of filings, most recently posting 1000.0 for Q4 2024.
- Cash from Discontinued Operations for Q4 2024 came in at 1000.0, down 99.9% year-over-year; the trailing twelve-month figure through Sep 2025 was 1000.0 (down 98.21% YoY), and the FY2024 annual result was 930000.0, up 88.61% from the prior year.
- Cash from Discontinued Operations came in at 1000.0 for Q4 2024 at Mimedx, up from 1000.0 in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of 987000.0 in Q4 2023 to a low of 4648000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -59.14 Mn |
| 10 | Mimedx | 546.28 Mn | 386.51 Mn | 41.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Jun 30, 2024 | -123,000.00 |
| Jun 30, 2024 | -123,000.00 |
| Mar 31, 2024 | -807,000.00 |
| Mar 31, 2024 | -807,000.00 |
| Dec 31, 2023 | 987,000.00 |
| Dec 31, 2023 | 987,000.00 |
| Sep 30, 2023 | -309,000.00 |
| Sep 30, 2023 | -309,000.00 |
| Jun 30, 2023 | -4.19 Mn |
| Jun 30, 2023 | -4.19 Mn |
| Mar 31, 2023 | -4.65 Mn |
| Mar 31, 2023 | -4.65 Mn |